Aclarion, Inc. (ACONW) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Aclarion, Inc.
Address
951 Mariners Island Boulevard
Broomfield, CA 94404
United States of America (the)
Phone
650-241-1741
Website
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Employees
11
First IPO Date
April 22, 2022
Key Executives
| Name | Title | Pay | Year Born |
| Brent Ness | Chief Executive Officer, President & Director | 462,500 | 1967 |
| Ryan Bond | Chief Strategy Officer | 254,167 | 1972 |
| Gregory A. Gould | Chief Financial Officer | 297,590 | 1966 |
| Jeffrey John Thramann | Executive Chairman | 462,500 | 1965 |
Description
Aclarion, Inc. is a healthcare technology firm specializing in software development for magnetic resonance spectroscopy (MRS) within the U.S. market. Its flagship product is the NOCISCAN-LS Post-Processor suite. This comprehensive suite includes NOCICALC-LS, which processes magnetic resonance spectroscopy (MRS) data from spinal discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a vital clinical decision support tool. Initially named Nocimed, Inc., the company adopted the Aclarion, Inc. moniker in December 2021. Established in 2008, Aclarion, Inc. maintains its headquarters in San Mateo, California.
